| It is generally agreed that,
of all the diseases that threaten
health, prosperity and quality
of life today, neurological disorders
must rank among the most important.
Throughout the world, the prevalence
of such disorders represents an
incalculable sum of suffering
for patients, families and carers,
and an enormous burden on economic
and healthcare resources. |
 |
 |
|
| Yet, the complexity of these disorders
is such that the pace of investigation
and discovery of disease mechanisms
and therapeutic agents capable of modifying
them has been necessarily slow, requiring
relentless commitment to research and
continuous long-term investment.
|
|
